StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix cash

Cash and short-term investments held at the end of each period.

Renalytix's cash was $909.00K at Sep 30, 2024. For fiscal 2024 it was $4.68M, down 81.0% from the year before. The highest annual figure on record is $65.13M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2024Jun 30, 2024$4.68M-81.0%
FY2023Jun 30, 2023$24.68M-40.3%
FY2022Jun 30, 2022$41.33M-36.5%
FY2021Jun 30, 2021$65.13M+356.2%
FY2020Jun 30, 2020$14.28M+55.2%
FY2019Jun 30, 2019$9.20M+11113.4%
FY2018Jun 30, 2018$82.00K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2025CQ3 2024Sep 30, 2024$909.00K-93.5%
Q4 FY2024CQ2 2024Jun 30, 2024$4.68M-81.0%
Q3 FY2024CQ1 2024Mar 31, 2024$4.70M-85.8%
Q2 FY2024CQ4 2023Dec 31, 2023$5.62M-76.4%
Q1 FY2024CQ3 2023Sep 30, 2023$13.89M-55.2%
Q4 FY2023CQ2 2023Jun 30, 2023$24.68M-40.3%
Q3 FY2023CQ1 2023Mar 31, 2023$33.03M+2.1%
Q2 FY2023CQ4 2022Dec 31, 2022$23.82M-40.4%
Q1 FY2023CQ3 2022Sep 30, 2022$31.04M-52.3%
Q4 FY2022CQ2 2022Jun 30, 2022$41.33M+189.5%
Q3 FY2022CQ1 2022Mar 31, 2022$32.36M+251.9%
Q2 FY2022CQ4 2021Dec 31, 2021$39.93M+48592.7%
Q4 FY2021CQ2 2021Jun 30, 2021$65.13M–
Q4 FY2020CQ2 2020Jun 30, 2020$14.28M–
Q4 FY2019CQ2 2019Jun 30, 2019$9.20M–
Q4 FY2018CQ2 2018Jun 30, 2018$82.00K–

More Renalytix figures

See a number that looks wrong?